Nga Rewa Houston

Title: Nga Rewa Houston: Innovator in Cancer Therapeutics

Introduction

Nga Rewa Houston is a notable inventor based in Lebanon, NH, who has made significant contributions to the field of cancer therapeutics. With a single patent to her name, she has focused on advanced solutions targeting specific proteins involved in cancer progression.

Latest Patents

Houston's patent, titled "Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor," encompasses innovative dual specificity antibodies that can bind to either PD-L1 or PD-L2. These antibodies hold promise for treating various cancers, particularly those that express or overexpress these proteins, potentially offering new avenues for cancer therapy.

Career Highlights

Nga Rewa Houston is affiliated with the University of Texas System, where her work emphasizes the intersection of immunology and cancer treatment. Her research has positioned her as a vital contributor to advancing cancer care through innovative antibody solutions.

Collaborations

Throughout her career, Houston has collaborated with esteemed colleagues, including Michael A. Curran and Ashvin R. Jaiswal. These partnerships highlight the collaborative spirit essential in research and development within the competitive landscape of medical innovations.

Conclusion

Nga Rewa Houston’s innovative work in developing dual specificity antibodies underscores her role as a key inventor in the fight against cancer. With her foundational patent, she paves the way for future advancements that could reshape cancer therapies and improve outcomes for patients.